This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European peripheral vascular stents market. Major topics covered by this report include a discussion of current and emerging peripheral vascular stenting technologies; a clinical overview of peripheral vascular conditions targeted by stenting, and an analysis of the European markets for iliac artery stents, fem-pop stents, TIPS devices, renal artery stents, AAA repair stent-grafts, and carotid artery stents.
EXECUTIVE SUMMARY i. Stent Design ii. Procedure Volumes iii. Market Analysis a. Iliac Artery Stents b. Femoropopliteal Stents c. Transjugular Intrahepatic Portosystemic Shunts d. Renal Artery Stents e. Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts f. Carotid Artery Stents Exhibit ES-1: Europe, Peripheral Vascular Stenting, Combined Procedure Volumes Forecast, 2010-2014 Exhibit ES-2: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014 1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES 1.1 Stent Design 1.1.1 Vascular Stents 1.1.2 Nonvascular Stents 1.1.3 Stent Deployment Mechanisms 1.2 Stent Materials 1.2.1 Metal Stents 184.108.40.206 Absorbable Magnesium Alloys 220.127.116.11 Cobalt Alloys 18.104.22.168 Nickel-Titanium Alloys 22.214.171.124 Stainless Steel 1.2.2 Standard Polymeric Stents 1.2.3 Biodegradable Polymeric Stents 1.3 Stent Coatings 1.3.1 Radiopacity Enhancement 1.3.2 Biocompatibility Enhancement 1.3.3 Active Therapeutic Enhancement 126.96.36.199 Drug-Eluting Stents 188.8.131.52.1 Antirestenotic Drug-Eluting Stents 184.108.40.206.2 Drug Delivery Techniques 1.3.4 Stent Coverings and Linings Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials Exhibit 1-4: Selected Polymeric Stent Materials Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents 2. OVERVIEW OF STENTING FOR PERIPHERAL VASCULAR APPLICATIONS 2.1 Cardiovascular Disease 2.1.1 Incidence and Prevalence 2.2 Peripheral Vascular Disease 2.2.1 Peripheral Artery Disease 220.127.116.11 Carotid Artery Disease 18.104.22.168 Lower Extremity Peripheral Artery Disease 22.214.171.124 Mesenteric Artery Disease 126.96.36.199 Renal Artery Stenosis 188.8.131.52 Aneurysm 184.108.40.206.1 Abdominal Aortic Aneurysm 220.127.116.11 Other Types of Peripheral Artery Disease 2.2.2 Peripheral Venous Disorders 18.104.22.168 Chronic Venous Insufficiency 22.214.171.124 Thrombophlebitis 126.96.36.199 Varicose Veins 2.2.3 Causes 188.8.131.52 Atherosclerosis 184.108.40.206.1 Incidence and Prevalence 220.127.116.11.2 Treatment 18.104.22.168 Hypertension 22.214.171.124.1 Incidence and Prevalence 126.96.36.199.2 Treatment 188.8.131.52 Diabetes 184.108.40.206.1 Type 1 Diabetes 220.127.116.11.2 Type 2 Diabetes 18.104.22.168.3 Macrovascular Disease 22.214.171.124.4 Hyperglycemia and Atherosclerosis 126.96.36.199.5 Hyperinsulinemia and Atherosclerosis 188.8.131.52.6 Incidence and Prevalence 184.108.40.206.7 Treatment 2.2.4 Surgical Intervention 220.127.116.11 Ablative Laser-Assisted Angioplasty 18.104.22.168 Bypass Grafting 22.214.171.124 Catheter-Based Thrombolysis and Mechanical Thrombectomy 126.96.36.199 Cryo-Balloon Angioplasty 188.8.131.52 Endarterectomy 184.108.40.206 Percutaneous Transluminal Angioplasty 220.127.116.11 Peripheral Atherectomy 18.104.22.168 Vascular Brachytherapy 22.214.171.124 Intravascular Stenting 126.96.36.199.1 Drug-Eluting Stents Exhibit 2-1: 2008, Europe, Cardiovascular Disease-Related Deaths, by Country Exhibit 2-2: The Peripheral Arteries Exhibit 2-3: Arteries of the Head and Neck Exhibit 2-4: Arteries of the Lower Body Exhibit 2-5: Classification of Abdominal Aortic Aneurysms Exhibit 2-6: 2008, Europe, Deaths Due to Ischemic Heart Disease, by Age Exhibit 2-7: 2004, Systolic Blood Pressure Levels in Selected European Countries Exhibit 2-8: 2010, Europe, Diabetes Prevalence, by Country 3. EUROPEAN PERIPHERAL VASCULAR STENTS MARKET 3.1 Iliac Artery Stents 3.1.1 Products and Technologies 3.1.2 Market Analysis 3.1.3 Competitive Analysis 3.2 Femoropopliteal Stents 3.2.1 Products and Technologies 3.2.2 Market Analysis 3.2.3 Competitive Analysis 3.3 Transjugular Intrahepatic Portosystemic Shunts 3.3.1 Products and Technologies 3.3.2 Market Analysis 3.3.3 Competitive Analysis 3.4 Renal Artery Stents 3.4.1 Products and Technologies 3.4.2 Market Analysis 3.4.3 Competitive Analysis 3.5 Endovascular Abdominal Aortic Aneurysm Repair Stent-Grafts 3.5.1 Products and Technologies 3.5.2 Market Analysis 3.5.3 Competitive Analysis 3.6 Carotid Artery Stents 3.6.1 Products and Technologies 3.6.2 Market Analysis 3.6.3 Competitive Analysis 3.7 Combined Market Analysis 3.7.1 Market Drivers 3.7.2 Market Limiters 3.7.3 Market Forecast Exhibit 3-1: 2011, Selected Iliac Artery Stents Exhibit 3-2: Europe, Iliac Artery Stenting, Procedure Volumes Forecast, 2010-2014 Exhibit 3-3: Europe, Iliac Artery Stents, Market Forecast, 2010-2014 Exhibit 3-4: 2010, Europe, Iliac Artery Stents Market, Share by Supplier Exhibit 3-5: 2011, Selected Femoropopliteal Stents Exhibit 3-6: Europe, Femoropopliteal Stenting, Procedure Volumes Forecast, 2010-2014 Exhibit 3-7: Europe, Femoropopliteal Stents, Market Forecast, 2010-2014 Exhibit 3-8: 2010, Europe, Femoropopliteal Stents Market, Share by Supplier Exhibit 3-9: 2011, Selected Transjugular Intrahepatic Portosystemic Shunts Exhibit 3-10: Europe, Transjugular Intrahepatic Portosystemic Shunting, Procedure Volumes Forecast, 2010-2014 Exhibit 3-11: Europe, Transjugular Intrahepatic Portosystemic Shunts, Market Forecast, 2010-2014 Exhibit 3-12: 2010, Europe, Transjugular Intrahepatic Portosystemic Shunts Market, Share by Supplier Exhibit 3-13: 2011, Selected Renal Artery Stents 3-32 Exhibit 3-14: Europe, Renal Artery Stenting, Procedure Volumes Forecast, 2010-2014 Exhibit 3-15: Europe, Renal Artery Stents, Market Forecast, 2010-2014 Exhibit 3-16: 2010, Europe, Renal Artery Stents Market, Share by Supplier Exhibit 3-17: 2011, Selected Endovascular Abdominal Aortic Aneurysm Stent-Grafts Exhibit 3-18: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Graft Repair, Procedure Volumes Forecast, 2010-2014 Exhibit 3-19: Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts, Market Forecast, 2010-2014 Exhibit 3-20: 2010, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier Exhibit 3-21: 2011, Selected Carotid Artery Stents Exhibit 3-22: Europe, Carotid Artery Stenting, Procedure Volumes Forecast, 2010-2014 Exhibit 3-23: Europe, Carotid Artery Stents, Market Forecast, 2010-2014 Exhibit 3-24: 2010, Europe, Carotid Artery Stents Market, Share by Supplier Exhibit 3-25: Europe, Peripheral Vascular Stents, Combined Market Forecast, 2010-2014 4. COMPANY PROFILES 4.1 Abbott Laboratories 4.2 C.R. Bard, Inc. 4.3 Boston Scientific Corporation 4.4 Cook Group, Inc. 4.5 ev3, Inc./Covidien, Inc. 4.6 W.L. Gore & Associates, Inc. 4.7 Johnson & Johnson 4.8 Medtronic, Inc.